Cannell Capital GAIN THERAPEUTICS INC ownership

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 17 filers reported holding GAIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Cannell Capital ownership history of GAIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$102,7510.00%